Histone Deacetylase Inhibition Activity and Molecular Docking of (E )-Resveratrol: Its Therapeutic Potential in Spinal Muscular Atrophy
about
Drug treatment for spinal muscular atrophy types II and IIIDrug treatment for spinal muscular atrophy types II and IIIMolecular Mechanisms of Neurodegeneration in Spinal Muscular AtrophyHistone deacetylase inhibitors as potential treatment for spinal muscular atrophyResveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cellsActivation of the stress proteome as a mechanism for small molecule therapeutics.Histone deacetylase (HDAC) inhibitory and antiproliferative activities of phenolic-rich extracts derived from the rhizome of Hydnophytum formicarum Jack.: sinapinic acid acts as HDAC inhibitor.Discovery, synthesis, and biological evaluation of novel SMN protein modulators.Epigenetic drugs: a novel anti-aging strategy?Naturally occurring plant polyphenols as potential therapies for inherited neuromuscular diseases.Developing therapies for spinal muscular atrophy.In silico studies in drug research against neurodegenerative diseases.Effects of flavonoid quercetin on survival of motor neuron gene expression.Carboxylic acid derivatives of histone deacetylase inhibitors induce full length SMN2 transcripts: a promising target for spinal muscular atrophy therapeutics.Investigations of curcumin and resveratrol on neurite outgrowth: perspectives on spinal muscular atrophy.Epigenetic Regulatory Mechanisms Induced by Resveratrol.Lignin-derived oak phenolics: a theoretical examination of additional potential health benefits of red wine.
P2860
Q24200270-1CAF91A6-92E7-4D26-815D-E73DFDC333AAQ24234414-6DE40C88-3502-4C10-93E0-1A7E6BE4F6EAQ26752798-C1226DD0-8E0C-4F61-9615-BD03E08E7D53Q26828876-59D679CF-582B-44D6-82DA-65271136B643Q28536197-6DAF235C-4D6F-4039-969B-97D688723BADQ34323595-A364884E-1965-4390-ABED-F8EC64F1BB23Q34992824-95352197-524D-4393-9361-30A98EA8EA28Q35216315-AA1D4B2A-6950-4BFC-8B7E-ADE0BACBCCAFQ36357400-BF6DA674-9C7D-498E-BF30-43F7A9FE3DA5Q38161550-09564224-A8F2-473D-B7A3-539FC3C5DB27Q38546908-85CDA0BE-0332-4471-BD5E-E2E0CB75EA52Q38638421-1E47D7AB-42C9-449E-8F6C-98A1D3C33135Q38947543-9F5C5F81-219B-4EF5-862F-68BAFD7CAE7EQ40414569-95A9A82A-73BA-45FF-8593-61F2F16F942AQ41917612-8B95B907-DB76-4E31-9C43-0085CE84F5ABQ47115527-2113F1FE-5EE3-4A57-92AA-CDF93A38AC77Q50554887-2105BEA9-13D9-4B16-88F2-544CD8FBF4C4
P2860
Histone Deacetylase Inhibition Activity and Molecular Docking of (E )-Resveratrol: Its Therapeutic Potential in Spinal Muscular Atrophy
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Histone Deacetylase Inhibition ...... ial in Spinal Muscular Atrophy
@ast
Histone Deacetylase Inhibition ...... ial in Spinal Muscular Atrophy
@en
type
label
Histone Deacetylase Inhibition ...... ial in Spinal Muscular Atrophy
@ast
Histone Deacetylase Inhibition ...... ial in Spinal Muscular Atrophy
@en
prefLabel
Histone Deacetylase Inhibition ...... ial in Spinal Muscular Atrophy
@ast
Histone Deacetylase Inhibition ...... ial in Spinal Muscular Atrophy
@en
P2093
P50
P3181
P1476
Histone deacetylase inhibition ...... ial in spinal muscular atrophy
@en
P2093
Ayhan S Demir
Didem Dayangaç-Erden
Peruze Ayhan
Sevim Dalkara
P304
P3181
P356
10.1111/J.1747-0285.2009.00781.X
P577
2009-03-01T00:00:00Z